Hood River Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.4M | Buy |
1,567,506
+11,018
| +0.7% | +$397K | 0.79% | 46 |
|
|
2025
Q1 | $61.4M | Buy |
1,556,488
+101,165
| +7% | +$3.99M | 1.05% | 38 |
|
|
2024
Q4 | $43.8M | Sell |
1,455,323
-175,026
| -11% | -$5.27M | 0.65% | 63 |
|
|
2024
Q3 | $38.1M | Buy |
1,630,349
+57,420
| +4% | +$1.34M | 0.62% | 63 |
|
|
2024
Q2 | $28M | Buy |
1,572,929
+98,892
| +7% | +$1.76M | 0.58% | 64 |
|
|
2024
Q1 | $22.4M | Buy |
+1,474,037
| New | +$22.4M | 0.5% | 69 |
|
|
2023
Q2 | – | Sell |
-739,112
| Closed | -$11.1M | – | 145 |
|
|
2023
Q1 | $11.1M | Buy |
+739,112
| New | +$11.1M | 0.36% | 72 |
|
|
2022
Q1 | – | Sell |
-963,762
| Closed | -$18.3M | – | 160 |
|
|
2021
Q4 | $18.3M | Buy |
963,762
+609,756
| +172% | +$11.6M | 0.55% | 64 |
|
|
2021
Q3 | $11.8M | Sell |
354,006
-13,498
| -4% | -$449K | 0.36% | 77 |
|
|
2021
Q2 | $14.3M | Sell |
367,504
-5,234
| -1% | -$203K | 0.42% | 78 |
|
|
2021
Q1 | $18M | Buy |
+372,738
| New | +$18M | 0.58% | 69 |
|